NASDAQ
3.38USD
+0.55 (+19.43%)
We have scored 4 news catalysts on Valion Bio, Inc. (VBIO) over the past 12 months. The biggest single-day move next to one of them came Jul 22, 2026, when VBIO closed −8.4%: “Ukraine Ministry of Health Accepts Entolimod Dossier for Formal Review Under Regulatory Equivalence Pathway”. Coverage across the window leans positive (average ticker sentiment +0.85). Most of the impact sits in short squeeze potential and forward growth expectations.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
11.7M
P/E
—
EPS
—
Beta
1.79
52W range
2.05-78.75
Day range
3.21–4.39
Open
4.00
Prev close
2.83
Volume
45.9M
Avg volume
430K
Dividend
0.00
IPO
2021-11-11
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Valion Bio, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for VBIO: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
